Salem Investment Counselors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
AI
Salem Investment Counselors's CRL Position: Q2 2026 in Review
Salem Investment Counselors held its Charles River Laboratories (CRL) position steady in Q2 2026 at 145 shares worth $32.9K. The position accounts for ﹤0.01% of the portfolio, ranked #694.
Salem Investment Counselors first reported a position in CRL in Q4 2020 and has held it in 22 quarters since. The position peaked at $60K in Q3 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Salem Investment Counselors held 145 shares of Charles River Laboratories worth $32.9K as of Q2 2026.
- Salem Investment Counselors left its Charles River Laboratories share count unchanged in Q2 2026.
- Charles River Laboratories made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #694 holding.
- Salem Investment Counselors first reported a position in Charles River Laboratories in Q4 2020 and has held it in 22 quarters since.
- Salem Investment Counselors's Charles River Laboratories position peaked at $60K in Q3 2021.
- 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.